http://pharmababble.disqus.com/Stream of consciousness pharmaceuticals business developmentenSat, 10 Jan 2009 10:55:12 -0000http://www.pharmababble.com/alnylam-and-cubist-to-codevelop-respiratory-syncytial-virus-rsv-infection-therapy/#comment-5044840<p>We'll see... All big Pharma had cb1 programs six months ago too...</p>TheEbenSat, 10 Jan 2009 10:55:12 -0000http://www.pharmababble.com/alnylam-and-cubist-to-codevelop-respiratory-syncytial-virus-rsv-infection-therapy/#comment-5043862<p>So far I have seen only positive interest - Roche, Takeda, Merk, Biogen, Novartis, AZN, PFE... virtually all big pharma has RNAi programs, and ALNY is the gate keeper. Keep looking</p>VioSat, 10 Jan 2009 09:39:31 -0000http://www.pharmababble.com/alnylam-and-cubist-to-codevelop-respiratory-syncytial-virus-rsv-infection-therapy/#comment-5032810<p>Please don't invest in ALNY, no way.... just stay put and look at the ALNY shareholders prosper. I have been in ALNY since it was 6 and am quite happy with the current deal and the deals before. JM is doing great job advancing ALNY to a major biotech/pharma . RSV is a small piece of the big picture, but you my friend don't get. </p>VioFri, 09 Jan 2009 23:34:10 -0000http://www.pharmababble.com/alnylam-and-cubist-to-codevelop-respiratory-syncytial-virus-rsv-infection-therapy/#comment-5033054<p>All I can say is we'll see. Eventually RNAi will have to produce <br>results.... almost a decade has produced nothing, how long will it <br>take before you lose interest?</p>TheEbenFri, 09 Jan 2009 22:53:19 -0000